Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Japanese Journal of Clinical Oncology|October 31, 2019
Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1)Yoshinori Imamura, Naomi Kiyota, Gakuto Ogawa, et al.
Japanese Journal of Clinical Oncology|October 27, 2018
Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2)Takashi Matsuzuka, Naomi Kiyota, Junki Mizusawa, et al.
Oral Oncology|April 15, 2014
The role of initial neck dissection for patients with node-positive oropharyngeal squamous cell carcinomasTomohiro Sakashita, Akihiro Homma, Ryuichi Hayashi, et al.
International Journal of Clinical Oncology|July 26, 2012
Salvage surgery for recurrent oropharyngeal cancer after chemoradiotherapySatoshi Kano, Akihiro Homma, Ryuichi Hayashi, et al.
Oncology|March 15, 2013
Matched-pair analysis in patients with advanced oropharyngeal cancer: surgery versus concurrent chemoradiotherapySatoshi Kano, Akihiro Homma, Ryuichi Hayashi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 18, 2011
Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapySadamoto Zenda, Kazuto Matsuura, Hiroyuki Tachibana, et al.
Head & Neck|September 3, 2013
Effect of local extension sites on survival in locally advanced maxillary sinus cancerSatoshi Kano, Ryuichi Hayashi, Akihiro Homma, et al.
Head & Neck|April 10, 2014
Multi-institutional retrospective study for the evaluation of ocular function-preservation rates in maxillary sinus squamous cell carcinomas with orbital invasionTomohiro Sakashita, Ryuichi Hayashi, Akihiro Homma, et al.
Cancer Science|March 18, 2015
Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)Makoto Tahara, Naomi Kiyota, Junki Mizusawa, et al.
Head & Neck|June 26, 2020
Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141)Chia-Jui Yen, Naomi Kiyota, Nobuhiro Hanai, et al.
Pageof 4